Curaleaf Holdings (CURLF) Income from Non-Controlling Interests (2020 - 2026)

Curaleaf Holdings (CURLF) recorded quarterly Income from Non-Controlling Interests of -$16000.0 in Q1 2026, down 100.0% quarter-over-quarter from $2.2 billion in Q4 2025, and down 101.96% on a YoY basis from $817000.0 in Q1 2025.

Curaleaf Holdings (CURLF) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Curaleaf Holdings' Income from Non-Controlling Interests history runs 7 years deep, the most recent figure standing at -$16000.0 for Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests fell 101.96% year-over-year to -$16000.0; the TTM figure through Mar 2026 stood at $2.2 billion (up 71772.83% YoY), while the FY2025 annual figure was $2.9 million, up 144.3% from the prior year.
  • Income from Non-Controlling Interests was -$16000.0 for Q1 2026 at Curaleaf Holdings, down from $2.2 billion in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $2.2 billion in Q4 2025 to a low of -$2.7 billion in Q1 2024.
  • Historically, Income from Non-Controlling Interests has averaged -$209.2 million across 5 years, with a median of -$1.2 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Income from Non-Controlling Interests slumped 99941.36% in 2023, then soared 241858.24% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at -$2.4 million in 2022, then plunged by 99941.36% to -$2.4 billion in 2023, then soared by 99.96% to -$910000.0 in 2024, then jumped by 241858.24% to $2.2 billion in 2025, then sank by 100.0% to -$16000.0 in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$16000.0 (Q1 2026), $2.2 billion (Q4 2025), and -$445000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Curaleaf Holdings - - 157.29 Mn -16,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -16,000.00
Dec 31, 2025 2.20 Bn
Jun 30, 2025 -445,000.00
Mar 31, 2025 817,000.00
Dec 31, 2024 -910,000.00
Sep 30, 2024 -2.03 Mn
Jun 30, 2024 -945,000.00
Mar 31, 2024 -2.70 Bn
Dec 31, 2023 -2.42 Bn
Sep 30, 2023 -1.38 Mn
Jun 30, 2023 -3.25 Mn
Dec 31, 2022 -2.42 Mn
Sep 30, 2022 -2.77 Mn
Jun 30, 2022 127,000.00
Dec 31, 2021 -2.54 Mn
Sep 30, 2021 -2.36 Mn
Jun 30, 2021 -1.84 Mn
Mar 31, 2021 363.00
Dec 31, 2020 165.00
Jun 30, 2020 193.00